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Panax ginseng is one of the most important medicinal plants in Asia. Triterpene saponins, known as
ginsenosides, are the major pharmacological compounds in P. ginseng. The present study was conducted
to evaluate the changes in ginsenoside composition according to the foliation stage of P. ginseng cultured
in a hydroponic system. Among the three tested growth stages (closed, intermediate, and opened), the
highest amount of total ginsenoside in the main and ﬁne roots was in the intermediate stage. In the
leaves, the highest amount of total ginsenoside was in the opened stage. The total ginsenoside content of
the ginseng leaf was markedly increased in the transition from the closed to intermediate stage, and
increased more slowly from the intermediate to opened leaf stage, suggesting active biosynthesis of
ginsenosides in the leaf. Conversely, the total ginsenoside content of the main and ﬁne roots decreased
from the intermediate to opened leaf stage. This suggests movement of ginsenosides during foliation
from the root to the leaf, or vice versa. The difference in the composition of ginsenosides between the leaf
and root in each stage of foliation suggests that the ginsenoside proﬁle is affected by foliation stage, and
this proﬁle differs in each organ of the plant. These results suggest that protopanaxadiol- and proto-
panaxatriol (PPT)-type ginsenosides are produced according to growth stage to meet different needs in
the growth and defense of ginseng. The higher content of PPT-type ginsenosides in leaves could be
related to the positive correlation between light and PPT-type ginsenosides.
opyright  2013, The Korean Society of Ginseng, Published by Elsevier.Open access under CC BY-NC-ND license. 1. Introduction
Panax ginseng Meyer is a slowly growing perennial herb
belonging to the Araliaceae family. It has been cultivated for its
highly valued roots and used in traditional medicine as a natural
adaptogen for >1000 yr [1]. Ginseng has numerous pharmacolog-
ical effects on humans, including anticancer [2e4], antidiabetic
[5,6], immunomodulatory [2,7], neuroprotective [2], radioprotec-
tive [8], antiamnestic [2], and antistress [9] properties. Most of the
medicinal effects of ginseng have been attributed to triterpene
saponins, which are referred to as ginsenosides. More than 40
ginsenosides have been isolated and identiﬁed fromwhite and red
ginseng, showing different biological activities based on their
structural differences [10e15]. Two types constitute >80% of the
identiﬁed ginsenosides: protopanaxadiol (PPD)-type saponins
(sugar moieties are attached to the b-OH at C-3 and/or C-20) such
as ginsenosides Rb1, Rb2, Rc, and Rd, and protopanaxatriol (PPT)-edicinal Materials and Processing,
inseng, Published by Elsevier. Opetype saponins (sugar moieties are attached to the a-OH at C-6 and/
or b-OH at C-20) such as ginsenosides Re, Rg1, and Rf [16].
The cultivation of P. ginseng is difﬁcult due to the long duration
(4e6 yr) needed for cultivation, and due to plant diseases such as
red skin and root rot. Furthermore, ginseng needs to be cultivated
under special conditions to meet its requirements of about 30% full
sunlight. High exposure to light (50% solar radiation) decreases the
levels of ginsenosides in Panax pseudoginseng [17], while exposure
to >36% sunlight has been reported to cause photobleaching and
leaf death in P. ginseng plants [18]. Although there have been many
studies on the production of ginsenoside using tissue and cell
cultures, the productivity has been low. To meet the demand for
safe agricultural products of high quality, the cultivation of ginseng
by hydroponics was developed in Korea [19,20]. This technique
involves a shorter period by cultivation in a greenhouse in which
variables such as light, temperature, moisture, and carbon dioxide
content can be controlled. Hydroponic systems can produceCollege of Life Science, Kyung Hee University, Suwon 449-701, Korea.
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ginsenoside contents [19,20].
Ginsenosides are distributed in many parts of the ginseng plant,
including the root, leaf, andberry. Different parts of the plant contain
distinct ginsenoside proﬁles [2], which may exhibit different phar-
macological activities. Although the P. ginseng root has been the
main component in medicinal uses of ginseng, recent studies have
revealed that the leaf and root hair contain higher ginsenoside levels
than the root [21]. Ginseng berries contain ginsenoside levels that
are 4.8 times higher than the levels in cultivated 4-yr ginseng roots,
with the levels of the ginsenoside Re being 28 times higher in the
berry than in the root [22,23]. Ginsenoside content in the root and
root hair increases with age in P. ginseng plants from 1 yr to 5 yr, but
it decreases with age in the leaves, except there is no alternation in
the 3-yr-old stage [21]. Although several studies have evaluated the
ginsenoside content in different parts of the plant at different ages,
there have been no studies investigating the ginsenoside proﬁle of
plants in different foliation stages. The present studywas conducted
to investigate the changes in ginsenoside composition in the leaves
and root of 3-yr-old ginseng plants cultivated by hydroponics ac-
cording to their foliation stage.
2. Materials and methods
2.1. Ginseng materials
Samples were obtained from 3-yr-old ginseng plants hydro-
ponically cultured in perlite and peat moss and grown at 23  2CFig. 1. Phenological growth stage of ginseng during foliation. Three-year-old ginseng plant
analysis and RNA extraction, the leaf, main root, and ﬁne root were sampled at different stage
(A) Closed-up leaf and inﬂorescence. (B) Whole plants during foliation stage.under white ﬂuorescent light (60e100 mmol/m2/s) in a controlled
greenhouse (kindly provided by i-farm in Yeoju, Korea). For the
ginsenoside analysis and RNA extraction, the plant leaves, main
roots, and ﬁne roots were sampled at different stages during foli-
ation (Fig. 1).
2.2. Analysis of ginsenosides by HPLC
First, 0.8 g milled powder from heat-dried leaves, main roots,
and ﬁne roots was soaked in 80% methanol at 80C. After the liquid
evaporated, the residue was dissolved in water and extracted with
water-saturated n-butanol. The butanol layer was then evaporated
to produce a saponin fraction. Each sample was dissolved in
methanol (1 g/5 mL) and then ﬁltrated through a 0.45-mm ﬁlter for
HPLC analysis. The HPLC separation was carried out on an Agilent
1260 series HPLC system (Agilent, Palo Alto, CA, USA), equipped
with an autosampler and an UV detector using a C18 column
(4.6 mm  50 mm, 1.8 mm; Zorbax Eclipse Plus, Agilent). Gradient
elution was used using solvent A (100% acetonitrile) and solvent B
(100% water) at 38C using the following gradient program: 0e
4 min, 19% A (isocratic); 4e9 min, 19e25% A; 9e20 min, 25e40% A;
20e25 min, 40e56%; 25e28 min, 56e70% A; 28e29 min, 70e100%
A; 29e35 min, 100% A (isocratic); 35e36 min, 100e19% A; 36e
42 min, 19% A (isocratic). The ﬂow rate was kept at 1.2 mL/min, the
sample injection volume was 5 mL, and UV absorption was
measured at 203 nm. Quantitative analysis was performed using a
one-point curve method using external standards of authentic
ginsenosides.s hydroponically cultured in perlite and peat moss were sampled. For the ginsenoside
s during foliation, including the (a) closed, (b) intermediate, and (c) opened leaf stages.
J Ginseng Res 2014;38:66e72682.3. Quantiﬁcation of transcript levels
Total RNA was extracted from the frozen samples with the
RNeasy Plant Mini Kit (Qiagen, Valencia, CA, USA) including the
DNase I digestion step. Next, 2 mg total RNA was reverse tran-
scribed with the RevertAid H Minus M-MuLV reverse transcrip-
tase (Fermentas, Hanover, MD, USA). Real-time quantitative
polymerase chain reaction was performed using 100 ng cDNA in a
reaction volume of 10 mL using SYBR Green Sensimix Plus Master
Mix (Quantace, Watford, UK). The thermal cycler conditions
recommended by the manufacturer were used: 10 min at 95C,
followed by 40 cycles at 95C for 10 s, 60C for 10 s, and 72C for
20 s. The ﬂuorescent product was detected during the ﬁnal step
of each cycle. Ampliﬁcation, detection, and data analysis were
carried out on a Rotor-Gene 6000 real-time rotary analyzer
(Corbett Life Science, Sydney, Australia). The primers used were
50-CCT CGC CAG ATT TGG AGT AA-30 and 50-GCA CAG AAC CGG
AAG ATA GC-30 for PgSS (AB115496); 50-GAT GTG CCT GGA CAA
AAG GT-30 and 50-AGG ATG GCG CGC ATA TTG AAA G-30 for PgSE
(AB122078); 50-GAG AGA TCC GAC ACC TCT GC-30 and 50-ATT TTG
AGC TGC TGG TGC TT-30. To determine the relative fold-differ-
ences in template abundance for each sample, the Ct values for
each of the gene-speciﬁc primers were normalized to the Ct value
for b-actin (50-AGA GAT TCC GCT GTC CAG AA-30 and 50-ATC AGC
GAT ACC AGG GAA CA-30) and calculated relative to a calibrator
using the formula 2DDCt.
2.4. Statistical analysis
The values of the ginsenoside contents and relative gene
expression were expressed as mean  standard deviation. Statis-
tical analyses were carried out using GraphPad Prism software (San
Diego, CA, USA) by one-way analysis of variance. Duncan’s multiple
range test was used to test for signiﬁcant differences between the
treatments at p < 0.05 and p < 0.01.Fig. 2. Ginsenoside contents of leaves from Panax ginseng during foliation. (A) Closed, inte
dicates 1 cm. (B) Total ginsenoside content in the leaves were analyzed. (C) The maj
mean  standard error from three independent experiments.3. Results
3.1. Ginsenoside contents during foliation
The ginsenoside contents of the ginseng leaves and roots were
evaluated at different foliation stages. As a perennial herbal plant,
ginseng leaves fall and sprout annually, with ﬂowers and berries
developing in the 3rd yr of growth. As shown in Fig. 1, we sampled
three different stages of leaves, which we referred to as (a) “closed”,
(b) “intermediate”, and (c) “opened”, from 3-yr-old ginseng plants
cultured by hydroponics. When the ginseng plants sprouted, their
leaves appeared closed (Figs.1 and 2A) and they had an average leaf
length of 3 cm, an average shoot height of 7 cm, and an average
main root length of 9 cm (Fig. 1Ba). In this early developmental
stage, the ﬂower bud was already formed, although the peduncle
was short (Fig. 2A). In the intermediate leaf stage (Fig. 2A), the
average leaf length was 4.5 cm and the average peduncle length
was 4.5 cm. After foliation, the leaves expanded (Fig. 2A) and the
ﬂower buds started to bloom (Fig. 1Ac), showing an average leaf
length of 6 cm and an average peduncle length similar to that of the
intermediate stage. During foliation, the shoot continued to elon-
gate to 10 cm in the intermediate stage (Fig.1Bb), and grew to 18 cm
in the open leaf stage (Fig. 1Bc). The main root did not elongate, but
the ﬁne roots grew out sideways during foliation (Fig. 1Bb and Bc).
Before foliation, the total ginsenoside content in the closed
leaves was the lowest among the different leaf stages (10.9 mg/g
dry weight). As shown in Fig. 2B, the total ginsenoside content
during foliation increased rapidly (by 3 times) from the closed to
the intermediate stage (30.8 mg/g dry weight), and then slowly (by
1.2 times) from the intermediate to the opened stage (38.3 mg/g).
All individual ginsenosides, with the exception of the ginsenoside
Rb1, increased three to four times from the closed to the interme-
diate leaf stage (Fig. 2C). In contrast, as shown in Fig. 3A and C, the
total ginsenoside content in the main root (12.3e12.5 mg/g) and
the ﬁne root (18e20.1 mg/g) did not signiﬁcantly increase from thermediate, and opened leaf stages were considered in the ginsenoside analysis. Bar in-
or individual ginsenosides in the leaves were analyzed. Vertical bars indicate the
A B
C D
Fig. 3. Ginsenoside contents of roots from Panax ginseng during foliation. The total ginsenoside content in the (A) main root and (C) ﬁne root was analyzed according to the closed,
intermediate, and opened leaf stages in Fig. 1. The major individual ginsenosides in the (B) main root and (D) ﬁne root were analyzed. Vertical bars indicate the mean  standard
error from three independent experiments.
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ginsenoside contents decreased by about 0.7 times in both themain
root (7.5 mg/g) and the ﬁne root (15.1 mg/g).
3.2. Ginsenoside proﬁles during foliation
The ratio of PPD-type ginsenosides (Rb1, Rb2, Rc, and Rd) to PPT-
type ginsenosides (Rg1, Re, and Rh1) changed during foliation
(Table 1). In the transition from the closed to the intermediate
stage, this ratio increased in the main and ﬁne roots. In particular,
PPT-type ginsenosides such as Rg1 and Re decreased, while PPD-
type ginsenosides increased in the main and ﬁne roots of plants in
the intermediate leaf stage, with the exception of the PPT-type
ginsenoside Rh1. Interestingly, the PPD/PPT ratio decreased in theTable 1
The ginsenoside compositions of the leaf, main root, and ﬁne root during foliation in clo
Ginsenosides Leaf
Closed Intermediate Opened Closed
Total ginsenosides1) 10.92  0.30 30.82  0.82 38.28  0.80 12.29  0.43
PPD2) 1.65  0.05 5.04  0.18 6.12  0.20 6.28  0.19
PPT3) 9.27  0.28 25.78  0.58 32.16  0.51 6.01  0.25
PPD/PPT 0.18 0.20 0.19 1.04
Rb1/total ginsenoside 0.04 0.02 0.01 0.36
Re/total ginsenosides 0.70 0.67 0.63 0.25
Rg1/total ginsenoside 0.13 0.14 0.19 0.21
All values are expressed as mean  standard error (n ¼ 3).
PPD, protopanaxadiol; PPT, protopanaxatriol.
1) Sum of individual ginsenosides content.
2) Rb1 þ Rb2 þ Rc þ Rd.
3) Re þ Rg1 þ Rh1.ﬁne roots after foliation. The levels of the ginsenosides Rg1 and Re
increased by 1.2 and 2 times, respectively, while all other ginse-
noside levels decreased.
The ratios of themain ginsenosides Rb1, Re, and Rg1 also changed
in different organs during foliation (Table 1). In leaves, the per-
centage of the ginsenosides Re and Rb1 decreased, although their
absolute contents increased during foliation. However, the percent-
age of Rg1 among the total ginsenosides increased. In themain roots,
the ratio of Re to the total ginsenosides decreased during foliation,
while the ratio of Rb1 to the total ginsenosides increased. The ﬁne
roots showed a similar ginsenoside pattern to that of the main roots
in the closed and the intermediate stage, but showed a different
pattern in the opened leaf stage. The ratios of the PPT-type ginse-
nosides Re and Rg1 to the total ginsenoside content increased.sed, intermediate, and opened leaf stage
Main root Fine root
Intermediate Opened Closed Intermediate Opened
12.46  0.43 7.51  0.22 17.97  0.75 20.06  0.70 15.06  0.62
7.14  0.24 4.28  0.13 11.68  0.45 14.18  0.46 6.49  0.29
5.32  0.19 3.23  0.10 6.29  0.34 5.88  0.27 8.57  0.34
1.34 1.33 1.86 2.41 0.76
0.38 0.39 0.41 0.43 0.29
0.23 0.19 0.18 0.15 0.25
0.17 0.21 0.13 0.11 0.30
J Ginseng Res 2014;38:66e72703.3. Biosynthesis of ginsenoside-related genes during foliation
As shown in Fig. 4D, ginsenoside is biosynthesized in ginseng by
the mevalonic acid pathway. To investigate ginsenoside biosyn-
thesis, we conducted a real-time polymerase chain reaction to
analyze the expression of squalene synthase (PgSS), squalene
epoxidase (PgSE), and dammarenediol synthase (PgDDS) genes in
leaves during foliation. Expression of PgSS and PgSE increased about
1.5 times in the intermediate and opened leaf stage (1.48- and 1.65-
fold, respectively, for PgSS; 1.53- and 1.62-fold, respectively, for
PgSE). The transcript levels of PgDDS under conditions of interme-
diate stage and opened stage were 4.2- and 4.6-fold higher,
respectively, than that of the closed leaf stage.
4. Discussion
In this study, we used 3-yr-old hydroponic-cultured ginseng for
ginsenoside analysis. Ginseng grown with this method has a
different ginsenoside composition compared with that of soil-
cultivated ginseng, as shown in a study of 1-yr-old ginseng by Kim
et al [20]. First, the leaves and roots of hydroponic ginseng contain
the ginsenoside Rh1, which is not detected in soil-cultivated
ginseng roots [19]. Rh1 has been reported to possess antiallergic
and anti-inﬂammatory activities [24]. Second, hydroponic-cultured
leaves contain a lower ratio of PPD/PPT (0.19) compared with soil-
cultivated ginseng leaves (0.35), as shown by Han et al [25]. In
particular, the percentage of the ginsenoside Re in hydroponic-
cultured ginseng leaves (about 60%) was about three times higher
than in its root (about 20%). Soil-cultivated ginseng leaves alsoA B
DC
Fig. 4. Expression of genes related to ginsenoside biosynthesis in leaves during foliation. Th
and opened leaves was analyzed by real-time polymerase chain reaction. Vertical bars indica
biosynthetic pathway in ginseng. PPD, protopanaxadiol; PPT, protopanaxatriol.contain the highest amount of Re compared with the other ginse-
nosides, but this amount is only 40e50% of the total ginsenoside
content [21]. Re is well known to be a physiologically active sub-
stance with anti-inﬂammatory effects [26] and antidiabetic activ-
ities [27]. The levels of this ginsenoside can reach up to 60% in
ginseng berries [23]; the highest amount found in the ginseng
plant. Based on these ﬁndings, hydroponic culturing of ginseng
leaves can be used to produce Re. These data conﬁrm that the
composition of individual ginsenosides may differ depending on
the cultivation system [20]. The higher content of PPT-type ginse-
nosides in leaves could be related to the positive correlation be-
tween light and PPT-type ginsenosides, which corresponds with
the observation that high light transmission increased PPT-type
ginsenosides in the leaves of ginseng plants [19].
To the best of our knowledge, information about the changes in
ginsenoside content in the leaves and roots of ginseng during its
different foliation stages has not been reported. During foliation,
the production and composition of ginsenosides changes in leaves
and roots (summarized in Fig. 5). The total ginsenoside content
decreased in the roots (Fig. 3) and increased in the leaves (Fig. 2),
with an increased accumulation of genes related with ginsenoside
biosynthesis (Fig. 4) observed when the shoots elongated and the
leaves opened. After sprouting, the metabolites already stored in
the roots from the last season might be transported to parts of the
plant above ground. During photosynthesis, the main sugar
products are synthesized in the leaves and are transported to the
roots for storage. After the leaves open, PPT-type ginsenosides
might preferentially be synthesized and stored in the leaves, while
PPD-type ginsenosides seem to be preferentially stored in the2,3-oxidosqualene
PPD
Mevalonate 
Squalene
Squalene epoxidase
Dammarenediol synthase 
Squalene synthase
PPTCytochrome P450
Glucosyltransferases
e relative expression of (A) PgSS, (B) PgSE, and (C) PgDDS genes in closed, intermediate,
te the mean  standard error from three independent experiments. (D) The ginsenoside
A B C
Fig. 5. Summary of the changes in ginsenoside composition in the leaf (-), main root (C), and ﬁne root (:) during foliation as divided into the closed (A), intermediate (B), and
opened (C) leaf stage. The black-boxed picture suggests the possibility for ginsenoside movement. PPD, protopanaxadiol; PPT, protopanaxatriol.
Y.-J. Kim et al / Ginsenosides during foliation 71roots, suggesting the possibility of the movement of ginsenosides
between the roots, shoots, and leaves. Although there have not
been any studies investigating the movement of ginsenosides in
ginseng, there is evidence for this phenomenon. One recent study
showed that the ginsenoside Rb1 is localized in the chloroplasts,
peroxisomes, and cytoplasm of leaf parenchyma, but not the vac-
uoles. However, Rb1 is localized in the vascular bundles as well as
the vacuoles in the leaf stem and the root parenchymal cells [28].
Leaf cells do not seem to be the storage site of Rb1, therefore, the
authors suggest that Rb1 can be biosynthesized in both peroxi-
somes and chloroplasts and then transported to the roots through
the phloem.
During the growth of the ginseng plant, ginsenoside composi-
tion changed in the leaves and roots. The ginsenosides Re and Rb1
were especially prevalent in the leaf and root, respectively. These
results suggest that individual ginsenosides have different roles in
the growth and defense systems of ginseng. For example, ﬁne roots
increase in number and length during ginseng growth and contain
increased PPT-type ginsenosides, especially Rg1, which might play
defensive or antioxidant roles in the plants [29]. Each ginsenoside
has been shown to have different pharmacological effects, such as
anti-aging [30], anti-diabetes [27], anti-inﬂammatory [31], and
anticancer such as the inhibition of tumor-induced angiogenesis
[32e34], anti-tumor activity and the prevention of tumor invasion
and metastasis [35,36]. Generally, saponins have been suggested to
be involved in plant defense against pathogens and pests [37].
However, the physiological roles of saponin in ginseng plants have
not been investigated, despite many studies on the effects of gin-
senoside on the human body. One study showed that ginsenoside
has an important allopathic effect on the ginseng plant [38]. In
addition, PPT-type ginsenosides (but not PPD-type ginsenosides)
showed stimulatory effects on the radicle length of ginseng seed-
lings [38]. More research is needed to evaluate the effects of indi-
vidual ginsenosides on ginseng plant growth and defense in order
to better understand the physiological role of ginsenosides in the
ginseng plant.Conﬂicts of interest
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